allergic to glp 1 Hypersensitivity glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like rash to dulaglutide and literature review - Bianchi - 2024 - JEADV Clinical Practice The first successful desensitization protocol
Description
SeekPeptides exists specifically to help researchers separate real peptide science from marketing noise
Albiglutide: The HARMONY Outcomes trial (2018) reported a 22% MACE reduction (HR 0.78, 95% CI 0.680.90) in 9463 T2DM patients, driven by reduced MI [18]
References Liu QK
doi: 10.4093/DMJ.2019.0208 27 ZhaoLZhuCLuMChenCNieXAbudukerimuBet al
This positions Mounjaro as a potential game changer
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, et al
